Status:
UNKNOWN
Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants
Lead Sponsor:
American University of Beirut Medical Center
Conditions:
Respiratory Distress Syndrome, Newborn
Transient Tachypnea of the Newborn
Eligibility:
FEMALE
18-49 years
Phase:
PHASE2
Brief Summary
The hypothesis of the study is that administration of antenatal steroid to women at high risk of preterm birth after 34 weeks of gestation would reduce the risk of respiratory complications, specifica...
Eligibility Criteria
Inclusion
- Women between 34 0/7- 36 6/7 weeks of gestation
- High risk of preterm birth
Exclusion
- Multiple births
- Fetal congenital malformations
- A course of steroids within 2 weeks of randomization
- Multiple courses of steroids
- Chorioamnionitis
- Non reassuring fetal heart rate
- Obstetrical indication of delivery
- Active bleeding
- Pregnancy related hypertensive disorders
- Uncontrolled diabetes
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2013
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT01206946
Start Date
September 1 2010
End Date
September 1 2013
Last Update
June 23 2011
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
American University of Beirut Medical Center
Beirut, Lebanon
2
Bahman Hospital
Beirut, Lebanon
3
Hotel Dieu de France
Beirut, Lebanon
4
Rafik Hariri University Hospital
Beirut, Lebanon